<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881424</url>
  </required_header>
  <id_info>
    <org_study_id>2014_51</org_study_id>
    <secondary_id>2014-A01761-46</secondary_id>
    <nct_id>NCT02881424</nct_id>
  </id_info>
  <brief_title>Study of Familiarity in Alcohol Dependence</brief_title>
  <acronym>FALCO</acronym>
  <official_title>Study of Familiarity in Alcohol Dependence : an Hyperfamiliarity for Faces</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      Alcohol-dependence is a chronic disease with a high risk of relapse. The main therapeutic&#xD;
      outcome relies on relapse prevention which seeks to identify high risk situations and&#xD;
      individual's response to these situations especially the emotional response to social&#xD;
      environment. Alcohol-dependence also induces cognitive impairments leading to social&#xD;
      cognition impairments increasing the risk of relapse.&#xD;
&#xD;
      Familiarity is a key process in social interactions: it induces the feeling of prior&#xD;
      knowledge of a stimulus without remembering consciously its identity. Followed by a second&#xD;
      process based on the contribution of contextual information (recollection) familiarity allows&#xD;
      face recognition.&#xD;
&#xD;
      Main aim:&#xD;
&#xD;
      Study of familiarity for faces in alcohol-dependence&#xD;
&#xD;
      Secondary objectives:&#xD;
&#xD;
      Highlighting correlations between familiarity impairments and clinical outcomes&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Familiarity will be tested by a specific familiarity task using an original paradigm. This&#xD;
      paradigm allows the analysis of familiarity as a quantitative process as well as the analysis&#xD;
      of personal familiarity to each subject. Three familiar and three unfamiliar faces are&#xD;
      morphed in pairs for each participant. The displayed stimuli for each pair of faces are ten&#xD;
      morphs with 5 to 95% of familiar face increasing by 10%. Participants are asked to press a&#xD;
      button if the displayed stimulus seems familiar. At the end of the task each participant is&#xD;
      asked to name the identity of the familiar faces (true or false recognitions, true or false&#xD;
      omissions).&#xD;
&#xD;
      Each participant will undergo 2 visits.&#xD;
&#xD;
        -  First visit:&#xD;
&#xD;
             -  Checking the inclusion and non-inclusion criteria&#xD;
&#xD;
             -  Clinical report and alcohol consumption evaluation&#xD;
&#xD;
             -  Standardized psychiatric interview (Mini International Neuropsychiatric Interview -&#xD;
                MINI)&#xD;
&#xD;
             -  Neuropsychological tests (Montreal Cognitive Assessment - MoCA, &quot;Batterie Rapide&#xD;
                d'Efficience Frontale&quot; - BREF, &quot;Rappel Libre et Rappel Indicé à 16 items&quot; - Grober&#xD;
                &amp; Buschke 's test - RL/RI 16)&#xD;
&#xD;
        -  Second visit:&#xD;
&#xD;
             -  Checking the non-consumption of alcohol and other drugs (cannabis, amphetamine,&#xD;
                cocaine, methamphetamine, ecstasy, opioid)&#xD;
&#xD;
             -  Task of familiarity with a controlling task&#xD;
&#xD;
             -  Social cognition test (Movie for the Assessment of Social Cognition - MASC)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Familiarity threshold</measure>
    <time_frame>3 years</time_frame>
    <description>calculated from the psychometric function of each participant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alcohol consumption</measure>
    <time_frame>3 years</time_frame>
    <description>alcohol consumption evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MocA score</measure>
    <time_frame>3 years</time_frame>
    <description>Score at the Montreal Cognitive Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BREF score</measure>
    <time_frame>3 years</time_frame>
    <description>neuropsychological score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RL/RI score</measure>
    <time_frame>3 years</time_frame>
    <description>neuropsychological score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>non-consumption of alcohol duration</measure>
    <time_frame>3 years</time_frame>
    <description>non-consumption of alcohol duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>social cognition test</measure>
    <time_frame>3 years</time_frame>
    <description>social cognition test score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concomitant treatment</measure>
    <time_frame>3 years</time_frame>
    <description>concomitant treatment posology</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">42</enrollment>
  <condition>Alcohol Dependence</condition>
  <arm_group>
    <arm_group_label>alcohol-dependent patients</arm_group_label>
    <description>a group of 34 alcohol-dependent patients, currently abstinent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
    <description>a group of control subjects, without neurologic or psychiatric disease, matched for age and sex with the alcohol-dependent participants</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        34 participants will be included in 2 groups: one group of alcohol-dependent patients and&#xD;
        another group of control subjects matched for age and sex.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  For all participants:&#xD;
&#xD;
               -  With normal vision with or without glasses&#xD;
&#xD;
               -  Understanding the Note of information and signing the consent form&#xD;
&#xD;
          -  For alcohol-dependent patients:&#xD;
&#xD;
               -  Being diagnosed with severe alcohol addiction (according to DSM-5)&#xD;
&#xD;
               -  Currently abstinent&#xD;
&#xD;
          -  For control subjects:&#xD;
&#xD;
               -  Exclusion of severe alcohol addiction's diagnosis (according to DSM-5)&#xD;
&#xD;
               -  Without antecedent or current neurologic disease&#xD;
&#xD;
               -  Without antecedent or current psychiatric disease&#xD;
&#xD;
               -  Non-taking psychotropic drugs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  For all participants:&#xD;
&#xD;
               -  Pregnant or breast-feeding women&#xD;
&#xD;
               -  Cognitive impairment detected by a MoCA score inferior to &lt; 26/30&#xD;
&#xD;
               -  Physically or mentally not able to pass the tests of the study&#xD;
&#xD;
               -  Taking an unauthorized drug the month before entering the study (other&#xD;
                  psychotropic drugs than the ones used for withdrawal or alcohol related&#xD;
                  complications for patients and any psychotropic drug for control subject)&#xD;
&#xD;
               -  Being diagnosed with a severe addiction other than to caffeine or tobacco&#xD;
                  (according to DSM-5)&#xD;
&#xD;
               -  Criteria for a plausible fetal alcohol syndrome&#xD;
&#xD;
          -  For alcohol-dependent patients:&#xD;
&#xD;
               -  Being diagnosed with schizophrenia or bipolar disorder (according to DSM-5)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier COTTENCIN, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Lille - CSAPA</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital, Lille - Fontan 2</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>August 17, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2016</study_first_posted>
  <last_update_submitted>October 12, 2018</last_update_submitted>
  <last_update_submitted_qc>October 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Familiarity</keyword>
  <keyword>Recollection</keyword>
  <keyword>Face Recognition</keyword>
  <keyword>Alcohol dependence</keyword>
  <keyword>Social cognition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

